. 2017 May 8;42(1):97–100. doi: 10.5114/ceji.2016.65894

Table 3.

The changes in serum liver fibrosis indexes including haluronic acid (HA), collagen IV (C-IV), laminin (LN), and transforming growth factor-β₁ (TGF-β₁) of chronic hepatitis B after treatment

Group	HA (ng/l)	C-IV (ng/l)	LN (ng/l)	TGF-β1 (ng/l)
Control group	174.9 (38.53)^a	238.1 (109.82)^a	142.6 (76.09)^a	185.7 (78.16)^a
Treatment group	91.4 (24.17)^b	161.2 (72.64)^b	104.5 (64.86)^b	132.6 (65.94)^b

Values are expressed as mean (SD). Means with different superscript letters within a row indicate significant differences (p < 0.05)